Company Registration No. 01074105 (England and Wales)
BROADLEIGH NURSERIES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023
PAGES FOR FILING WITH REGISTRAR
BROADLEIGH NURSERIES LIMITED
COMPANY INFORMATION
Directors
Lady Skelmersdale
Lord Skelmersdale
Company number
01074105
Registered office
Barr House
Barr House
Bishops Hull
Taunton
Somerset
UNITED KINGDOM
TA4 1AE
Accountants
Apsleys Chartered Accountants
21 Bampton Street
Tiverton
Devon
EX16 6AA
BROADLEIGH NURSERIES LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
BROADLEIGH NURSERIES LIMITED
BALANCE SHEET
AS AT
30 NOVEMBER 2023
30 November 2023
- 1 -
2023
2022
Notes
£
£
£
£
Fixed assets
Tangible assets
3
7,642
8,305
Current assets
Stocks
349
649
Debtors
4
234
95
Cash at bank and in hand
20,434
24,945
21,017
25,689
Creditors: amounts falling due within one year
5
(15,650)
(18,871)
Net current assets
5,367
6,818
Total assets less current liabilities
13,009
15,123
Capital and reserves
Called up share capital
6
100
100
Profit and loss reserves
12,909
15,023
Total equity
13,009
15,123

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.

The financial statements were approved by the board of directors and authorised for issue on 9 August 2024 and are signed on its behalf by:
Lady Skelmersdale
Director
Company Registration No. 01074105
BROADLEIGH NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023
- 2 -
1
Accounting policies
Company information

Broadleigh Nurseries Limited is a private company limited by shares incorporated in England and Wales within the United Kingdom.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

1.2
Turnover

Turnover represents the total invoice value, excluding value added tax, of sales made during the year.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:

Portable buildings
Straight line over the life of the lease
Tools and equipment
15% reducing balance
Office equipment
25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Stocks

Stocks are stated at the lower of cost and net realisable value.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts.

BROADLEIGH NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2023
1
Accounting policies
(Continued)
- 3 -
1.6
Financial instruments

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

1.7
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 2 (2022 - 2).

3
Tangible fixed assets
Portable buildings
Tools and equipment
Office equipment
Total
£
£
£
£
Cost
At 1 December 2022 and 30 November 2023
11,024
26,636
10,939
48,599
Depreciation and impairment
At 1 December 2022
5,500
24,126
10,668
40,294
Depreciation charged in the year
220
376
67
663
At 30 November 2023
5,720
24,502
10,735
40,957
Carrying amount
At 30 November 2023
5,304
2,134
204
7,642
At 30 November 2022
5,524
2,510
271
8,305
4
Debtors
2023
2022
Amounts falling due within one year:
£
£
Other debtors
234
95
BROADLEIGH NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2023
- 4 -
5
Creditors: amounts falling due within one year
2023
2022
£
£
Trade creditors
540
1,612
Other taxation and social security
263
274
Other creditors
14,847
16,985
15,650
18,871
6
Called up share capital
2023
2022
£
£
Ordinary share capital
Issued and fully paid
100 Ordinary shares of £1 each
100
100
2023-11-302022-12-01false12 August 2024CCH SoftwareCCH Accounts Production 2024.100Growing, developing and trading bulbs and seedsLady SkelmersdaleLord Skelmersdalefalsefalse010741052022-12-012023-11-3001074105bus:Director12022-12-012023-11-3001074105bus:Director22022-12-012023-11-3001074105bus:RegisteredOffice2022-12-012023-11-30010741052023-11-30010741052022-11-3001074105core:LandBuildingscore:LeasedAssetsHeldAsLessee2023-11-3001074105core:PlantMachinery2023-11-3001074105core:ComputerEquipment2023-11-3001074105core:LandBuildingscore:LeasedAssetsHeldAsLessee2022-11-3001074105core:PlantMachinery2022-11-3001074105core:ComputerEquipment2022-11-3001074105core:CurrentFinancialInstruments2023-11-3001074105core:CurrentFinancialInstruments2022-11-3001074105core:Non-currentFinancialInstruments2023-11-3001074105core:ShareCapital2023-11-3001074105core:ShareCapital2022-11-3001074105core:RetainedEarningsAccumulatedLosses2023-11-3001074105core:RetainedEarningsAccumulatedLosses2022-11-3001074105core:LandBuildingscore:LeasedAssetsHeldAsLessee2022-12-012023-11-3001074105core:PlantMachinery2022-12-012023-11-3001074105core:ComputerEquipment2022-12-012023-11-30010741052021-12-012022-11-3001074105core:LandBuildingscore:LeasedAssetsHeldAsLessee2022-11-3001074105core:PlantMachinery2022-11-3001074105core:ComputerEquipment2022-11-30010741052022-11-3001074105bus:PrivateLimitedCompanyLtd2022-12-012023-11-3001074105bus:SmallCompaniesRegimeForAccounts2022-12-012023-11-3001074105bus:FRS1022022-12-012023-11-3001074105bus:AuditExemptWithAccountantsReport2022-12-012023-11-3001074105bus:FullAccounts2022-12-012023-11-30xbrli:purexbrli:sharesiso4217:GBP